Sotera Health (NASDAQ:SHC) Shares Sold by Verition Fund Management LLC

Verition Fund Management LLC reduced its stake in shares of Sotera Health (NASDAQ:SHC) by 40.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,104 shares of the company’s stock after selling 11,660 shares during the period. Verition Fund Management LLC’s holdings in Sotera Health were worth $286,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. CWM LLC lifted its position in Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after acquiring an additional 993 shares during the period. GAMMA Investing LLC raised its stake in shares of Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock worth $50,000 after purchasing an additional 1,660 shares during the last quarter. Capital Performance Advisors LLP acquired a new stake in shares of Sotera Health during the third quarter worth about $91,000. Point72 DIFC Ltd boosted its position in Sotera Health by 556.6% in the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after buying an additional 5,544 shares during the last quarter. Finally, Acadian Asset Management LLC increased its holdings in Sotera Health by 728.0% in the 2nd quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after buying an additional 8,248 shares during the period. 91.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Royal Bank of Canada restated an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Citigroup upped their price target on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Finally, The Goldman Sachs Group started coverage on Sotera Health in a research note on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective for the company. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Sotera Health currently has a consensus rating of “Moderate Buy” and an average target price of $16.08.

Sotera Health Trading Down 1.9 %

Shares of Sotera Health stock opened at $13.15 on Friday. The firm has a 50-day simple moving average of $14.61 and a two-hundred day simple moving average of $14.16. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44. The company has a market cap of $3.72 billion, a P/E ratio of 52.60 and a beta of 1.96.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. During the same period in the previous year, the company posted $0.18 EPS. The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. As a group, equities analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.